Table 3.
Patient characteristics
| Stable atherosclerosis (n= 24) | NSTEMI (n= 18) | P-value | |
|---|---|---|---|
| Age (years) | 61 (±10) | 57 (±10) | 0.24 |
| Male (n, %) | 21 (88) | 14 (78) | 0.68 |
| Treated with PCI (n, %) | 20 (83) | 9 (50) | 0.04 |
| Use of DES (n, %) | 16 (80) | 7 (78) | 0.90 |
| Angiography alone (n, %) | 4 (17) | 9 (50) | 0.05 |
| BMI | 29.0 (±3.8) | 29.3 (±4.8) | 0.84 |
| Number of risk factors per subject | 2.8 (±1.0) | 2.5 (±1.1) | 0.27 |
| Current smoker (n, %) | 2 (8) | 7 (39) | 0.04 |
| Hypertension (n, %) | 15 (63) | 10 (56) | 0.89 |
| Diabetes mellitus (n, %) | 6 (25) | 2 (11) | 0.50 |
| Hypercholesterolaemia (n, %) | 18 (75) | 10 (56) | 0.32 |
| Family history of IHD (n, %) | 12 (50) | 11 (61) | 0.69 |
| Other known vascular disease (n, %) | 7 (29) | 2 (11) | 0.34 |
| Prescribed statin therapy (n, %) | 21 (88) | 17 (94) | 0.82 |
| ACEI/ARB (n, %) | 18 (75) | 14 (78) | 0.88 |
| Long-acting nitrate (n, %) | 3 (13) | 1 (6) | 0.77 |
| Calcium channel blocker (n, %) | 10 (42) | 0 | 0.01 |
| Aspirin and clopidogrel (n, %) | 1 (4) | 18 (100) | <0.01 |
| Haemoglobin (g/dL) | 14.5 (±1.2) | 14.5 (±1.5) | 0.92 |
| White cell count (×109/L) | 7.6 (±1.3) | 8.6 (±3.5) | 0.23 |
| Platelet count (×109/L) | 261 (±80) | 277 (±53) | 0.50 |
| Serum creatinine (µmol/L) | 92.8 (±15.0) | 90.8 (±16.1) | 0.68 |
| Total cholesterol (mmol/L) | 4.4 (±0.8) | 4.6 (±1.0) | 0.46 |
| HDL-C (mmol/L) | 1.1 (±0.3) | 0.9 (±0.2) | 0.10 |
| TC:HDL-C ratio | 4.1 (±1.0) | 5.5 (±1.6) | 0.01 |
| TNI (µg/L) | N/A | 2.1 (±2.7) | N/A |
BMI, body mass index; RF, risk factor; ACEI, angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor antagonist; HDL-C, high-density lipoprotein cholesterol; TC:HDL-C, total cholesterol: high-density lipoprotein cholesterol; TNI, troponin-I.